These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27626193)

  • 1. Pharma and Academia: What We Have Here Is a Failure to Communicate.
    Birnbaum MJ
    Cell Metab; 2016 Sep; 24(3):365-367. PubMed ID: 27626193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American Thoracic Society, San Francisco, California.
    Rosenblatt M
    Ann Am Thorac Soc; 2013 Feb; 10(1):31-8. PubMed ID: 23509330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthened ties between industry and academia are historical, productive, and crucial.
    Haller JA
    Surv Ophthalmol; 2014; 59(3):348-53. PubMed ID: 24656436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaboration between academia and pharma to bring new therapies to market more important than ever.
    Caffrey MK
    Am J Manag Care; 2014 Feb; 20(2 Spec No.):E14. PubMed ID: 25764579
    [No Abstract]   [Full Text] [Related]  

  • 5. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharma pursues novel models for academic collaboration.
    Hughes B
    Nat Rev Drug Discov; 2008 Aug; 7(8):631-2. PubMed ID: 18670424
    [No Abstract]   [Full Text] [Related]  

  • 7. Building bridges between academia and industry: forms; foundations; functions.
    Bander KW; Rosenberg LE
    Yale J Biol Med; 1997; 70(3):213-7. PubMed ID: 9544491
    [No Abstract]   [Full Text] [Related]  

  • 8. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
    Vallance P; Williams P; Dollery C
    Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
    [No Abstract]   [Full Text] [Related]  

  • 9. At issue: A model for academic/industry collaboration.
    Carpenter WT; Koenig JI; Bilbe G; Bischoff S
    Schizophr Bull; 2004; 30(4):997-1004. PubMed ID: 15954203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open for collaboration: an academic platform for drug discovery and development at SciLifeLab.
    Arvidsson PI; Sandberg K; Forsberg-Nilsson K
    Drug Discov Today; 2016 Oct; 21(10):1690-1698. PubMed ID: 27373760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborations between academic psychiatry and the pharmaceutical industry: a perspective from industry.
    Tohen M
    Epidemiol Psichiatr Soc; 2007; 16(3):197-8. PubMed ID: 18020191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical industry, academia and patient advocacy organizations: what is the recipe for synergic (win-win-win) collaborations?
    Rose DM; Marshall R; Surber MW
    Respirology; 2015 Feb; 20(2):185-91. PubMed ID: 25580960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical issues for effective collaboration between academia and industry in the field of regenerative medicine in Japan.
    Tsubouchi M; Morishita R; Tabata Y; Matsui S; Kawakami K
    Regen Med; 2008 Jul; 3(4):497-504. PubMed ID: 18588472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outlook: finding improved medicines: the role of academic-industrial collaboration.
    Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
    Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melding regulatory, pharmaceutical industry, and U.S. payer perspectives on improving approaches to heterogeneity of treatment effect in research and practice.
    Willke RJ; Crown W; Del Aguila M; Cziraky MJ; Khan ZM; Migliori R
    Value Health; 2013; 16(6 Suppl):S10-5. PubMed ID: 24034306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Academia-pharma intersect: providing a broader perspective on drug development synergies between academia and industry.
    Chabner BA
    Oncologist; 2010; 15(1):1-2. PubMed ID: 20086167
    [No Abstract]   [Full Text] [Related]  

  • 17. Partnerships between academic psychiatry and the pharmaceutical industry: the Lilly MAP Initiative.
    Singh B; Copolov D; Grainger D; Goh J
    Australas Psychiatry; 2004 Sep; 12(3):220-4; discussion 225-6. PubMed ID: 15715778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Academic-Pharma drug discovery alliances: seeking ways to eliminate the valley of death.
    Hammonds T
    Future Med Chem; 2015; 7(14):1891-9. PubMed ID: 26393391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Academic medical centers and the pharmaceutical industry.
    Del Parigi A
    Clin Pharmacol Ther; 2010 Oct; 88(4):464-5. PubMed ID: 20703224
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.